Core-Shell Nano Constructs for Cancer Theragnostic Core-Shell Nano Constructs for Cancer Theragnostic

Core-Shell Nano Constructs for Cancer Theragnostic

Current Scenario, Challenges and Regulatory Aspects

    • USD 189.99
    • USD 189.99

Descripción editorial

This book addresses the critical challenge in cancer treatment, focusing on the precise delivery of therapeutic agents to cancer cells while sparing healthy tissue. It emphasizes the limitations of current cancer therapies and highlights the potential of nanotechnology to revolutionize cancer treatment. It discusses how core-shell nano constructs, with their enhanced stability, biocompatibility, and targeting capabilities, emerge as a promising solution. The book covers the synthesis of novel core-shell nano constructs while elaborating on the chemistry involved in their fabrication. It explores various therapeutic and diagnostic applications of these nano constructs in cancer treatment, considering different materials such as polymers, lipids, and metals and the importance of diagnostics, biosensors, and targeting strategies to achieve site-specific delivery while minimizing toxicity to healthy cells.

Additionally, the book addresses regulatory and commercialization aspects,emphasizing the need for comprehensive characterization techniques to assess the effectiveness of core-shell nano constructs. This book is an invaluable resource for students, researchers, and professionals in the field.

GÉNERO
Técnicos y profesionales
PUBLICADO
2025
9 de abril
IDIOMA
EN
Inglés
EXTENSIÓN
644
Páginas
EDITORIAL
Springer Nature Singapore
VENDEDOR
Springer Nature B.V.
TAMAÑO
49.9
MB
Advanced Targeting of the Lymphatic System Advanced Targeting of the Lymphatic System
2024
Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems
2022
Sustainable Nanotechnology Sustainable Nanotechnology
2022
Drug Delivery for the Retina and Posterior Segment Disease Drug Delivery for the Retina and Posterior Segment Disease
2018